@article{f3fd27986f784496bbb9e3ab13e43580,
title = "BQ.1.1, XBB.1, and XBB.1.5 neutralization after bivalent mRNA COVID-19 booster in patients with cancer",
abstract = "Ehmsen et al. evaluate the neutralizing capacity to current SARS-CoV-2 variants in patients with cancer before and after receiving the BNT162b2 bivalent mRNA vaccine booster. Bivalent vaccine provides some protection against BQ.1.1 but fails to protect against XBB.1 and XBB.1.5 in patients with cancer.",
keywords = "BNT162 Vaccine, COVID-19/prevention & control, Humans, Neoplasms/genetics, RNA, Messenger/genetics, SARS-CoV-2/genetics",
author = "Sidse Ehmsen and Pedersen, {Rune M} and Bang, {Line L} and Anders Asmussen and Amalie Kragh and Holm, {Dorte K} and Sydenham, {Thomas V} and Jensen, {Th{\o}ger G} and Jeppesen, {Stefan S} and Henrik Frederiksen and Andersen, {Thomas E} and Ditzel, {Henrik J}",
note = "Copyright {\textcopyright} 2023 Elsevier Inc. All rights reserved.",
year = "2023",
month = apr,
day = "10",
doi = "10.1016/j.ccell.2023.02.003",
language = "English",
volume = "41",
pages = "649--650",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "4",
}